Free Access
| Issue |
Med Sci (Paris)
Volume 24, Number 3, Mars 2008
|
|
|---|---|---|
| Page(s) | 228 - 231 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2008243228 | |
| Published online | 15 March 2008 | |
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s health Initiative randomized controlled trial. JAMA 2002; 288 : 321–33. [Google Scholar]
- Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s health initiative randomized controlled trial. JAMA 2004; 291 : 1701–12. [Google Scholar]
- Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997; 17 : 3071–8. [Google Scholar]
- Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362 : 428–32. [Google Scholar]
- Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115 : 840–5. [Google Scholar]
- Aiach M, Alhenc-Gelas M, Borgel D, et al. Mutations des protéines de la coagulation et thromboses. Med Sci (Paris) 2006; 22 : 985–9. [Google Scholar]
- Straczek C, Oger E, Yon de Jonage-Canonico MB, et al. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Circulation 2005; 112 : 3495–500. [Google Scholar]
- Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study. J Thromb Haemost 2006; 4 : 1259–65. [Google Scholar]
- Oger E, Alhenc-Gelas M, Lacut K, et al. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arterioscler Thromb Vasc Biol 2003; 23 : 1671–6. [Google Scholar]
- Arnal JF, Gourdy P, Garmy-Susini B, et al. Effets vasculaires des œstrogènes. Med Sci (Paris) 2003; 19 : 1226–32. [Google Scholar]
- Rexrode KM, Manson JE. Are some types of hormone therapy safer than others ? Lessons from the Estrogen and Thromboembolism Risk study. Circulation 2007; 115 : 820–2. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.